Emergent BioSolutions (EBS) Posts Q1 EPS of $0.08, Short of Views; Reaffirms Outlook
Tweet Send to a Friend
Emergent BioSolutions (NYSE: EBS) reports Q1 EPS ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
